T-cell Therapy Market: Industry Analysis and Forecast (2021-2027) by Modality, Therapy Type, Indication, and Region

T-cell Therapy Market size was valued at US$ 6.4 Bn. in 2020 and the total revenue is expected to grow at 19.8% through 2021 to 2027, reaching nearly US$ 22.67 Bn.

T-cell Therapy Market Overview:

Antigen receptor chimeric (CAR) T-cell therapy is a technique for genetically altering T cells (a kind of white blood cell) in the lab such that they can discover and destroy cancer cells. Because it includes changing the genes inside T cells to help them attack cancer, CAR T-cell therapy is sometimes referred to as a sort of cell-based gene therapy. T-cell Therapy MarketTo know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2026. 2020 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on he demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

T-cell Therapy Market Dynamics:

In the coming years, rising approvals combined with improving manufacturing capabilities are expected to increase market rivalry in T-cell therapy businesses. The European Medicines Agency, for example, approved Kite Pharma's Tecartus, the sole CAR-T therapy treatment for mantle cell lymphoma, in December 2020. The rapidly growing gene therapy market is critical to the success of CAR-T medicines. With increased investments in the field of gene therapy, this market is projected to continue to rise. Companies like Novartis AG are aggressively researching the possibility of CAR-T-based gene treatments for a variety of chronic diseases. T-cell-based mechanisms are now commonly used in cancer immunotherapy due to their increased success rate. More than 350 CAR-T clinical trials have been registered in China as of June 2020. This research shows that Chimeric Antigen Receptor therapy is becoming increasingly important in cancer treatment. Furthermore, to increase their market positions, the majority of operational companies are investing in CD19 CAR-T therapies in the near future. Also, rapid innovation in cell therapy technologies is projected to further flourish the growth of market expansion. In addition, the global COVID-19 pandemic has sparked interest in researching the use of T-cell treatments in viral infection studies. This therapy has the potential to treat high-risk COVID-19 patients, according to research released in December 2020. Similarly, the US FDA approved ALVR109's IND application to treat COVID-19 patients in September 2020. T-cell therapies for viral infections are anticipated to become more popular as a result of this.

T-cell Therapy Market Segment Analysis:

The Research segment is anticipated to adhere to the growth of the T-cell Therapy Market. The research segment dominated the T-cell therapy market, accounting for more than 75.4 % of revenue share in 2020 owing to rising clinical research studies and product development by pharmaceutical industries. A large number of research institutes, such as Mayo Clinic, are actively involved in CAR-T therapy initiatives, indicating that the technology is a viable option for cancer treatment. Numerous effective businesses are engaging with research communities all around the world, resulting in a shift in emphasis toward speeding the development of CAR-T therapies to broaden the therapeutic application landscape. Immuneel Therapeutics, for example, joined with the Institute investigations Biomèdiques August Pi I Sunyer and the Hospital Clinic de Barcelona in October 2020 to develop and commercialize CAR-T therapy in India. The CART-cell segment is supplementing the growth of the T-cell Therapy Market. The CAR T-cell treatment category dominated the T-cell therapy market in 2020, accounting for the biggest revenue share of 82.2 %. This is due to the enormous amount of clinical studies for CAR-T therapies, as well as the growing involvement of prominent companies in the field. A large number of new entrants and academic institutions are undertaking clinical studies for CAR-T therapy available for different and equivalent indications, bolstering the segment's dominance. The use of CAR-T therapies in the treatment of various tumors has increased thanks to advancements in CAR-T therapy production. New techniques, such as second-generation, next-generation CAR-T immunotherapy, may address problems like resistance and adverse effects, resulting in increased organic income generation. T-cell Therapy Market by Indication

T-cell Therapy Market Regional Insights:

North America dominated the T-cell therapy market in 2020, accounting for roughly 40.0 percent of total revenue. The dominance of the market in the region is due to the presence of good research, a commercial base, and a large number of clinical trials for T-cell treatments being done in the United States. Furthermore, the growing number of regulatory approvals in the United States and Canada, as well as the region's changing reimbursement picture, has hastened the penetration of these medicines, resulting in significant market growth. Furthermore, the presence of a large number of medical institutes that offer CAR-T cell therapy supports the regional market growth. Furthermore, conventional drug developers such as Pfizer and Amgen have entered this industry as a result of rising financial flows hence, this factor is estimated to lift the growth of the regional market in the forecast period. Sanofi's acquisition of Kiadis Pharma demonstrates multinational pharmaceutical corporations' rising interest in this field. The objective of the report is to present a comprehensive analysis of the T-cell Therapy Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the T-cell Therapy Market dynamics, structure by analyzing the market segments and project the T-cell Therapy Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the T-cell Therapy Market make the report investor’s guide.

T-cell Therapy Market Scope: Inquire before buying

T-cell Therapy Market by Scope  

T-cell Therapy Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

T-cell Therapy Market Key Players

Novartis AG • Merck KGaA • Gilead Sciences Inc. • TCR2 Therapeutics Inc • Bluebird Bio Inc. • Sorrento Therapeutics • Fate Therapeutics • Pfizer Inc. • Amgen • Celgene Corporation • Caribou Biosciences Inc. • Celyad (Belgium) • Bellicum Pharmaceuticals Inc. • Noile-Immune Biotech • Nanjing Legend Biotechnology Co. Ltd. • Johnson & Johnson • Sangamo Therapeutics Inc.

FAQs:

1. What is the T-cell Therapy Market value in 2020? Ans: The T-cell Therapy Market value in 2020 was estimated as 6.4 Billion USD. 2. Which segment is likely to dominate the T-cell Therapy Market growth? Ans: CAR T-cell therapy dominated the t-cell therapy market with a share of 82.2% in 2019. This is attributable to the recent approval of Kymriah & Yescarta that has accelerated R&D investments in this segment. 3. Which Region is expected to dominate the T-cell Therapy Market during the forecast period? Ans: North America dominated the T-cell Therapy Market with a share of 43.6% in 2019. This is attributable to the increasing number of surgeries and respiratory diseases and enhanced treatment options. 4. What are the factors driving the T-cell Therapy Market? Ans: Key factors that are driving the t-cell therapy market growth include improving the financing landscape for advanced therapies including cell & gene therapies coupled with technological advancements in the manufacturing process. 5. Who are the key players in the T-cell Therapy Market? Ans: Some key companies operating in the t-cell therapy market are Novartis AG; Gilead Sciences; bluebird bio, Inc.; Celgene Corporation, bluebird bio; TCR2 Therapeutics Inc.; Sorrento Therapeutics; and Fate Therapeutics.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Therapy Type 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Therapy Type 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Therapy Type 2.3.2. Primary Research 2.3.2.1. Data from Primary Therapy Type 2.3.2.2. Breakdown of Primary Therapy Type 3. Executive Summary: T-cell Therapy Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the T-cell Therapy Market 3.4. Geographical Snapshot of the T-cell Therapy Market, By Manufacturer share 4. T-cell Therapy Market Overview, 2020-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the T-cell Therapy Market 5. Supply Side and Demand Side Indicators 6. T-cell Therapy Market Analysis and Forecast, 2020-2027 6.1. T-cell Therapy Market Size & Y-o-Y Growth Analysis. 7. T-cell Therapy Market Analysis and Forecasts, 2020-2027 7.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 7.1.1. Research 7.1.2. Commercialized 7.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 7.2.1. CAR T-cell Therapy 7.2.2. T Cell Receptor (TCR)-based 7.2.3. Tumor Infiltrating Lymphocytes (TIL)-based 7.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 7.3.1. Hematologic Malignancies 7.3.1.1. Lymphoma 7.3.1.2. Leukemia 7.3.1.3. Myeloma 7.3.2. Solid Tumors 7.3.2.1. Melanoma 7.3.2.2. Brain & Central Nervous System 7.3.2.3. Liver Cancer 7.3.2.4. Others 7.3.3. Others 8. T-cell Therapy Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2020-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America T-cell Therapy Market Analysis and Forecasts, 2020-2027 9.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 9.1.1. Research 9.1.2. Commercialized 9.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 9.2.1. CAR T-cell Therapy 9.2.2. T Cell Receptor (TCR)-based 9.2.3. Tumor Infiltrating Lymphocytes (TIL)-based 9.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 9.3.1. Hematologic Malignancies 9.3.1.1. Lymphoma 9.3.1.2. Leukemia 9.3.1.3. Myeloma 9.3.2. Solid Tumors 9.3.2.1. Melanoma 9.3.2.2. Brain & Central Nervous System 9.3.2.3. Liver Cancer 9.3.2.4. Others 9.3.3. Others 10. North America T-cell Therapy Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. T-cell Therapy Market Analysis and Forecasts, 2020-2027 11.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 11.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 11.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 12. Canada T-cell Therapy Market Analysis and Forecasts, 2020-2027 12.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 12.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 12.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 13. Mexico T-cell Therapy Market Analysis and Forecasts, 2020-2027 13.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 13.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 13.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 14. Europe T-cell Therapy Market Analysis and Forecasts, 2020-2027 14.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 14.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 14.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 15. Europe T-cell Therapy Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K T-cell Therapy Market Analysis and Forecasts, 2020-2027 16.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 16.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 16.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 17. France T-cell Therapy Market Analysis and Forecasts, 2020-2027 17.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 17.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 17.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 18. Germany T-cell Therapy Market Analysis and Forecasts, 2020-2027 18.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 18.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 18.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 19. Italy T-cell Therapy Market Analysis and Forecasts, 2020-2027 19.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 19.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 19.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 20. Spain T-cell Therapy Market Analysis and Forecasts, 2020-2027 20.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 20.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 20.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 21. Sweden T-cell Therapy Market Analysis and Forecasts, 2020-2027 21.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 21.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 21.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 22. CIS Countries T-cell Therapy Market Analysis and Forecasts, 2020-2027 22.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 22.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 22.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 23. Rest of Europe T-cell Therapy Market Analysis and Forecasts, 2020-2027 23.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 23.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 23.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 24. Asia Pacific T-cell Therapy Market Analysis and Forecasts, 2020-2027 24.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 24.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 24.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 25. Asia Pacific T-cell Therapy Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China T-cell Therapy Market Analysis and Forecasts, 2020-2027 26.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 26.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 26.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 27. India T-cell Therapy Market Analysis and Forecasts, 2020-2027 27.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 27.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 27.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 28. Japan T-cell Therapy Market Analysis and Forecasts, 2020-2027 28.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 28.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 28.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 29. South Korea T-cell Therapy Market Analysis and Forecasts, 2020-2027 29.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 29.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 29.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 30. Australia T-cell Therapy Market Analysis and Forecasts, 2020-2027 30.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 30.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 30.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 31. ASEAN T-cell Therapy Market Analysis and Forecasts, 2020-2027 31.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 31.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 31.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 32. Rest of Asia Pacific T-cell Therapy Market Analysis and Forecasts, 2020-2027 32.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 32.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 32.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 33. Middle East Africa T-cell Therapy Market Analysis and Forecasts, 2020-2027 33.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 33.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 33.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 34. Middle East Africa T-cell Therapy Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa T-cell Therapy Market Analysis and Forecasts, 2020-2027 35.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 35.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 35.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 36. GCC Countries T-cell Therapy Market Analysis and Forecasts, 2020-2027 36.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 36.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 36.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 37. Egypt T-cell Therapy Market Analysis and Forecasts, 2020-2027 37.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 37.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 37.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 38. Nigeria T-cell Therapy Market Analysis and Forecasts, 2020-2027 38.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 38.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 38.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 39. Rest of ME&A T-cell Therapy Market Analysis and Forecasts, 2020-2027 39.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 39.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 39.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 40. South America T-cell Therapy Market Analysis and Forecasts, 2020-2027 40.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 40.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 40.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 41. South America T-cell Therapy Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil T-cell Therapy Market Analysis and Forecasts, 2020-2027 42.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 42.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 42.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 43. Argentina T-cell Therapy Market Analysis and Forecasts, 2020-2027 43.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 43.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 43.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 44. Rest of South America T-cell Therapy Market Analysis and Forecasts, 2020-2027 44.1. Market Size (Value) Estimates & Forecast By Modality, 2020-2027 44.2. Market Size (Value) Estimates & Forecast By Therapy Type, 2020-2027 44.3. Market Size (Value) Estimates & Forecast By Indication, 2020-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the T-cell Therapy Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Merck & Co., Inc. 45.3.1.1. Financial Overview 45.3.1.2. Geographic Footprint 45.3.1.3. Grade Portfolio 45.3.1.4. Business Strategy 45.3.1.5. Recent Developments 45.3.2. Novartis AG 45.3.3. Merck KGaA 45.3.4. Gilead Sciences Inc. 45.3.5. TCR2 Therapeutics Inc 45.3.6. Bluebird Bio Inc. 45.3.7. Sorrento Therapeutics 45.3.8. Fate Therapeutics 45.3.9. Pfizer Inc. 45.3.10. Amgen 45.3.11. Celgene Corporation 45.3.12. Caribou Biosciences Inc. 45.3.13. Celyad (Belgium) 45.3.14. Bellicum Pharmaceuticals Inc. 45.3.15. Noile-Immune Biotech 45.3.16. Nanjing Legend Biotechnology Co. Ltd. 45.3.17. Johnson & Johnson 45.3.18. Sangamo Therapeutics Inc Primary Key Insights

About This Report

Report ID 124121
Category Healthcare
Published Date Oct 2021
Updated Date
Contact Us